Clinical Trial

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Name: Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis — clinical trial record (NCT07236099)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)

Protocol Amendment History 1 change

notable Trial sites expanded: 16 -> 34 locations 2026-07-24

Trial Details

NCT Number	NCT07236099
Lead Sponsor	Beijing InnoCare Pharma Tech Co., Ltd.
Conditions	Prurigo Nodularis (PN)
Enrollment	135 participants
Start Date	2025-11-27
Primary Completion	2027-03 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-23